Price and reimbursement of advanced therapeutic medicinal products in Europe: are assessment and appraisal diverging from expert recommendations?

被引：0
|
作者：
Virginia Ronco
Myriam Dilecce
Elena Lanati
Pier Luigi Canonico
Claudio Jommi
机构：
[1] Market Access Provider Srl,Dipartimento di Scienze del Farmaco
[2] Università del Piemonte Orientale,SDA Bocconi School of Management
[3] Università Bocconi,undefined
来源：
Journal of Pharmaceutical Policy and Practice | / 14卷
关键词：
ATMPs; Pricing and reimbursement; HTA; Pipeline;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 11 条
  • [1] Price and reimbursement of advanced therapeutic medicinal products in Europe: are assessment and appraisal diverging from expert recommendations?
    Ronco, Virginia
    Dilecce, Myriam
    Lanati, Elena
    Canonico, Pier Luigi
    Jommi, Claudio
    JOURNAL OF PHARMACEUTICAL POLICY AND PRACTICE, 2021, 14 (01)
  • [2] REIMBURSEMENT OF ADVANCED THERAPY MEDICINAL PRODUCTS IN EUROPE
    Hanna, E.
    Marre, C.
    Toumi, M.
    VALUE IN HEALTH, 2018, 21 : S202 - S203
  • [3] THE REIMBURSEMENT STATUS OF ADVANCED THERAPY MEDICINAL PRODUCTS IN EUROPE
    Hanna, E.
    Marre, C.
    Toumi, M.
    VALUE IN HEALTH, 2019, 22 : S428 - S428
  • [4] Assessment of innovativeness, and price and reimbursement negotiation of medicines: recommendations of an expert panel
    Jommi, Claudio
    Patarnello, Francesca
    Bianchi, Cosetta
    Buzzetti, Giuliano
    GLOBAL & REGIONAL HEALTH TECHNOLOGY ASSESSMENT, 2024, 11 : 169 - 174
  • [5] PRICING AND REIMBURSEMENT MECHANISMS FOR ADVANCED THERAPEUTIC MEDICINAL PRODUCTS IN 20 COUNTRIES
    Rejon-Parrilla, J. C.
    Espin, J.
    Garner, S.
    Epstein, D.
    VALUE IN HEALTH, 2023, 26 (12) : S265 - S265
  • [6] REVIEW OF THE REIMBURSEMENT ENVIRONMENT FOR ADVANCED THERAPEUTIC MEDICINAL PRODUCTS (ATMPS) IN THE UK
    Hughes, T.
    Harries, M.
    Sattar, S.
    VALUE IN HEALTH, 2017, 20 (09) : A661 - A662
  • [7] THE CHALLENGES OF OUTCOMES-BASED REIMBURSEMENT FOR ADVANCED THERAPY MEDICINAL PRODUCTS IN EUROPE
    Wallace, M.
    Redman, N.
    VALUE IN HEALTH, 2022, 25 (12) : S251 - S251
  • [8] Linking Reimbursement to Patient Benefits for Advanced Therapy Medicinal Products and Other High-Cost Innovations: Policy Recommendations for Outcomes-Based Agreements in Europe
    Avsar, Tuba Saygin
    Elvidge, Jamie
    Hawksworth, Claire
    Kenny, Juliet
    Nemeth, Bertalan
    Callenbach, Marcelien
    Ringkvist, Johanna
    Dawoud, Dalia
    VALUE IN HEALTH, 2024, 27 (11) : 1497 - 1506
  • [9] CHARACTERISTICS AND OUTCOMES OF HEALTH TECHNOLOGY ASSESSMENT SUBMISSIONS FOR ADVANCED THERAPY MEDICINAL PRODUCTS IN EUROPE: PERSPECTIVE FROM NON-EU5 COUNTRIES
    Cardoso, A.
    Wallace, M.
    Jin, G.
    VALUE IN HEALTH, 2023, 26 (12) : S360 - S360
  • [10] Value attributes of advanced therapy medicinal products: a documentary analysis of comments received from stakeholders during reimbursement decisions to England's National Institute of Health and Care Excellence
    Ferizovic, Nermina
    Plackett, Ruth
    Clarke, Caroline S.
    Hunter, Rachael
    Freemantle, Nick
    EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2025, 25 (04) : 605 - 621
12